Ausgabe 3/2011
Inhalt (19 Artikel)
Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease
Kazuichi Okazaki, Kazushige Uchida, Masanori Koyabu, Hideaki Miyoshi, Makoto Takaoka
Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies
Shinji Tanaka, Shigeki Arii
Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in Japan
Michio Hongo, Hiroto Miwa, Motoyasu Kusano
Regulation of gastric acid secretion by the serum and glucocorticoid inducible kinase isoform SGK3
Venkanna Pasham, Anand Rotte, Madhuri Bhandaru, Melanie Eichenmüller, Henning Fröhlich, Andreas F. Mack, Diwakar Bobbala, Wenting Yang, David Pearce, Florian Lang
The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Tomowo Yoshida, Nobuya Ohara, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Kazuhide Yamamoto
Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group
Motohiko Kato, Tsutomu Nishida, Shusaku Tsutsui, Masato Komori, Tomoki Michida, Katsumi Yamamoto, Naoki Kawai, Shinji Kitamura, Shinichiro Zushi, Akihiro Nishihara, Fumihiko Nakanishi, Kazuo Kinoshita, Takuya Yamada, Hideki Iijima, Masahiko Tsujii, Norio Hayashi
Etiological difference between ultrashort- and short-segment Barrett’s esophagus
Juntaro Matsuzaki, Hidekazu Suzuki, Keiko Asakura, Yoshimasa Saito, Kenro Hirata, Toru Takebayashi, Toshifumi Hibi
CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid
Tsutomu Yoshida, Tsukasa Sekine, Ken-ichi Aisaki, Tetuo Mikami, Jun Kanno, Isao Okayasu
Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C
Hiroyasu Morikawa, Katsuhiko Fukuda, Sawako Kobayashi, Hideki Fujii, Shuji Iwai, Masaru Enomoto, Akihiro Tamori, Hiroki Sakaguchi, Norifumi Kawada
A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial
Takahiro Yamasaki, Satoe Hamabe, Issei Saeki, Yohei Harima, Yuhki Yamaguchi, Koichi Uchida, Shuji Terai, Isao Sakaida
Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts
Masatoshi Ishigami, Hideya Kamei, Taro Nakamura, Yoshiaki Katano, Hisami Ando, Tetsuya Kiuchi, Hidemi Goto
Clinicopathological features of severe and fulminant forms of autoimmune hepatitis
Shin Yasui, Keiichi Fujiwara, Yutaka Yonemitsu, Shigeto Oda, Masayuki Nakano, Osamu Yokosuka
Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure
Zhihui Xu, Xiaoqiang Ren, Yan Liu, Xiaodong Li, Siyu Bai, Yanwei Zhong, Lin Wang, Panyong Mao, Huifen Wang, Shaojie Xin, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Fabien Zoulim, Dongping Xu
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
Masayuki Kurosaki, Naoya Sakamoto, Manabu Iwasaki, Minoru Sakamoto, Yoshiyuki Suzuki, Naoki Hiramatsu, Fuminaka Sugauchi, Hiroshi Yatsuhashi, Namiki Izumi
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy
Hyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, Ju Hyun Kim, Soon-Ho Um, Soo Hyung Ryu, Young-Suk Lee, Young Soo Kim, Kwon Yoo, Joon-Yeol Han, Jae Seok Hwang, Tae-Hun Kim, Jin-Mo Yang, Heon-Ju Lee, Chae Yoon Chon, Mong Cho, Byung Hoon Han, Seong Gyu Hwang, Kwan Soo Byun, Young-Hwa Chung, Se-Hyun Cho, Kwang Cheol Koh, Byung-Ik Kim, Haak Cheoul Kim, Seung Woon Paik, Myung-Seok Lee, Hee-Won Yoo, Cheol Ju Han
Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis
Masato Yoneda, Koji Fujita, Kento Imajo, Hironori Mawatari, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima
Reply to the letter by M. Yoneda et al. regarding “Ezetimibe therapy in patients with nonalcoholic steatohepatitis”
Hyohun Park, Takeshi Okanoue
Visceral and subcutaneous fat accumulation and nonalcoholic fatty liver disease
Levent Filik
Reply to the letter by L. Filik regarding “Visceral and subcutaneous fat accumulation and nonalcoholic fatty liver disease”
Yuichiro Eguchi, Toshihiko Mizuta, Yoshio Sumida, Yoichiro Kitajima, Kazuma Fujimoto, Shunzo Koizumi